Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Design of novel zebrafish models of cystinosis

Sep. 16, 2019

Phase III AMPLIFY study of phosphate absorption inhibitor tenapanor meets primary endpoint

Sep. 4, 2019

Eli Lilly and Company describes PDE1 inhibitors

Sep. 3, 2019

Discovery and preclinical evaluation of SH-379 as a novel anti-LOH agent

Aug. 22, 2019

Initiator Pharma provides an update on IPED-2015 and IP-2018 development

Aug. 16, 2019

SHR-1653 as a novel highly potent and selective OTR antagonist

Aug. 14, 2019

Eloxx Pharmaceuticals initiates phase II study for ELX-02 in cystinosis

Aug. 6, 2019

Aronora opens phase II study of AB-002 in end-stage renal disease patients on chronic hemodialysis

Aug. 1, 2019

Roystonea regia lipid extract reduces lower urinary tract symptoms in men with BPH

July 26, 2019

Regulus outlines FDA requirements to reinitiate MAD studies with RGLS-4326

July 24, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...